N-Benzyl-3-sulfonamidopyrrolidines are a New Class of Bacterial DNA Gyrase Inhibitors.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  ACS Medicinal Chemistry Letters

• Publication date

  2011-04-14

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/ML1002822PMID 21552338PMCID PMC3088120
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• How antibiotics kill bacteria: from targets to networks

  2010cited by this paper
• Type IIA topoisomerase inhibition by a new class of antibacterial agents

  2010cited by this paper
• A domain insertion in Escherichia coli GyrB adopts a novel fold that plays a critical role in gyrase function

  2010cited by this paper
• Antibacterial Drug Discovery in the Age of Resistance: New technologies and partnerships are helping to meet the challenges of antibacterial R&D

  2010cited by this paper
• Mechanism of Action of the Antibiotic NXL101, a Novel Nonfluoroquinolone Inhibitor of Bacterial Type II Topoisomerases

  2008cited by this paper
• Mechanism of action of and resistance to quinolones

  2008cited by this paper
• Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains.

  2007cited by this paper
• N-Benzyl-3-sulfonamidopyrrolidines as novel inhibitors of cell division in E. coli.

  2007cited by this paper
• Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysis.

  2007cited by this paper
• Drugs for bad bugs: confronting the challenges of antibacterial discovery

  2007cited by this paper
• Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection

  2006cited by this paper
• Assembly of dimeric variants of coumermycins by tandem action of the four biosynthetic enzymes CouL, CouM, CouP, and NovN.

  2004cited by this paper
• Mutation Rate and Evolution of Fluoroquinolone Resistance in Escherichia coli Isolates from Patients with Urinary Tract Infections

  2003cited by this paper
• Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.

  2003cited by this paper
• Modulation of Antibiotic Efflux in Bacteria

  2002cited by this paper
• Activity of Quinolones Against Gram-Positive Cocci: Mechanisms of Drug Action and Bacterial Resistance

  2002cited by this paper
• The PyMOL Molecular Graphics System

  2002cited by this paper
• Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria.

  2001cited by this paper
• DNA gyrase as a drug target.

  1999cited by this paper
• DNA gyrase, topoisomerase IV, and the 4-quinolones

  1997cited by this paper
• Crystal structure of the breakage–reunion domain of DNA gyrase

  1997cited by this paper
• DNA gyrase as a drug target.

  1997cited by this paper
• Current Developments in the Chemistry of Artemisinin and Related Compounds

  1994cited by this paper
• Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli

  1990cited by this paper
• Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli

  1990cited by this paper

• FtsZ‐Independent Mechanism of Division Inhibition by the Small Molecule PC190723 in Escherichia coli

  2019cites this paper
• Non-quinolone Topoisomerase Inhibitors

  2018cites this paper
• The Macromolecular Machines that Duplicate the Escherichia coli Chromosome as Targets for Drug Discovery

  2018cites this paper
• Targeting quinolone- and aminocoumarin-resistant bacteria with new gyramide analogs that inhibit DNA gyrase.

  2017cites this paper
• Novel Antibacterial Compounds and their Drug Targets - Successes and Challenges.

  2017cites this paper
• Synthesis of new 7-chloro-4-phenoxyquinoline analogues as potential antitubercular agents

  2017cites this paper
• Three-component, one-pot synthesis of anthranilamide Schiff bases bearing 4-aminoquinoline moiety as Mycobacterium tuberculosis gyrase inhibitors.

  2017cites this paper
• DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens

  2017cites this paper
• Engineering another class of anti-tubercular lead: Hit to lead optimization of an intriguing class of gyrase ATPase inhibitors.

  2016cites this paper
• Protective Effect of Qnr on Agents Other than Quinolones That Target DNA Gyrase

  2015cites this paper
• Novel compounds targeting bacterial DNA topoisomerase/DNA gyrase.

  2014cites this paper
• NBTI 5463 is a novel bacterial type II topoisomerase inhibitor with Gram-6 negative antibacterial activity and in vivo efficacy

  2014cites this paper
• Non-quinolone inhibitors of bacterial type IIA topoisomerases: a feat of bioisosterism.

  2014cites this paper
• NBTI 5463 Is a Novel Bacterial Type II Topoisomerase Inhibitor with Activity against Gram-Negative Bacteria and In Vivo Efficacy

  2014cites this paper
• Efficacy In Vivo against Gram-Negative Bacteria and Topoisomerase Inhibitor with Activity NBTI 5463 Is a Novel Bacterial Type II

  2014cites this paper
• Gyramides Prevent Bacterial Growth by Inhibiting DNA Gyrase and Altering Chromosome Topology

  2014cites this paper
• Structure-activity studies of divin: an inhibitor of bacterial cell division.

  2013cites this paper
• Prospects for developing new antibacterials targeting bacterial type IIA topoisomerases.

  2013cites this paper
• Recent Developments in Inhibitors of Bacterial Type IIA Topoisomerases

  2013cites this paper
• Divin: a small molecule inhibitor of bacterial divisome assembly.

  2013cites this paper
• Chemical-biological studies of subcellular organization in bacteria.

  2011cites this paper